Menu
Enrolling by invitation NCT07285252

Evaluating Non-Invasive Haptics During Extreme Exercise

No phase Interventional VO2max Lactate Threshold Lactate

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Victory Patch with Haptic Vibrotactile Trigger Technology, Sham patch.
Who it may be relevant to
Registry conditions: VO2max, Lactate Threshold, Lactate. Basic parameters: 18 years — 85 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United Kingdom
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

ENDURE- Evaluating Non-Invasive Haptics During Extreme Exercise

Overview

This study aims to compare determinants of endurance performance between participants wearing an active patch with haptic vibrotactile trigger technology (VTT) versus a placebo patch without VTT among recreational to competitive runners over a 4-week training period.

Interventions

  • Device Victory Patch with Haptic Vibrotactile Trigger Technology
    Active Patch with Haptic Vibrotactile Trigger Technology
  • Device Sham patch
    Sham/Placebo Patch without Haptic Vibrotactile Trigger Technology

Primary outcome measures

  • Change in VO2 Max [Time frame: 2-weeks and 4-weeks after baseline assessment]
Secondary outcome measures (1)
  • Change in Lactate-threshold running speed [Time frame: 2-weeks and 4-weeks after baseline assessment]

Eligibility criteria

Inclusion criteria

  • Adults aged 18 years and over, that participate in recreational to competitive distance running (>2 structured runs per week), that were able to complete maximal treadmill exercise safely and were able to attend three laboratory visits were invited to participate.

Exclusion criteria

  • Adults with a contraindications to high-intensity treadmill exercise, cardiovascular, metabolic, or musculoskeletal conditions limiting participation, reported use of performance-enhancing drugs, pregnancy, known allergy to adhesives, or current use of neuromodulatory or haptic devices

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Non-randomized
Model
Parallel assignment
Masking
Double blind
Primary purpose
Basic science

Study locations

United Kingdom · 1 center
  • The Altitude Centre — London

Identifiers

NCT: NCT07285252 · ENDURE-001

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗